Cellectar Biosciences, Inc. (CLRB) NASDAQ

4.04

+0.24(+6.32%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap10.95M
Enterprise Value-11.84M
P/E Ratio-0.68
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio1.36
Enterprise/Revenue0
Enterprise/EBITDA-0.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.29
Return On Equity-1.91

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-51.49M
Net Income-44.58M
Diluted EPS-41.89

Balance Sheet

Total Cash12.55M
Total Cash/Share3.97
Total Debt431,929
Total Debt/Equity0.05
Current Ratio2.77
Book Value Per Share2.97

Price History

52-Week Change-52.19
52-Week High20.7
52-Week Low2.45
Moving Average 50 Days3.25
Moving Average 200 Days5.75

Statistics

Average Volume164,936
Shares Outstanding3.19M
% Held by Institutions0.16

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateJune 24, 2025